Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent... ...http://www.moneycontrol.com/news/business/q3-results-five-trends-to-watch-outindian-drugmakers_8268581.html
Sun continues to bolster its specialty pipeline—Tildrakizumab (Merck), Odomzo (Novartis), MM-II (Moebius), Seciera (Ocular), Elepsia/Xelpros... ...http://www.financialexpress.com/industry/morgan-stanley-rates-sun-pharmaceutical-industries-equal-weight/502309/
Why is it that there are just a handful of manufacturers and of those, a very insignificant number are Indian owned? Is there a need for a... ...http://www.bloombergquint.com/opinion/2017/01/03/price-control-wont-make-stents-more-accessible
BOGOTA (Reuters) - Colombia's government has lowered the price of Novartis cancer drug imatinib by nearly half in a bid to cut healthcare costs... ...https://in.news.yahoo.com/colombia-cuts-price-novartis-cancer-drug-44-percent-134821417.html
MRRS adds "Global Hematological Cancers Market to 2022 Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market"... ...http://pressreleaseping.com/pressrelease/220769.html
For Buying Imatinib & Gleevec Online...
Gleevec 100mg tablets are a new type...
Imatinib mesylate 400mg tablets is a...